Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 9/20 | 0.36 |
| ▸ | IKZF2 | Q9UKS7 | 1/20 | 0.32 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.30 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.30 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PLK1 | P53350 | 1/20 | 0.30 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.30 |
| ▸ | CDC42BPA | Q5VT25 | 1/20 | 0.30 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.30 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.30 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19286271 | 0.87 | KAT2B (0.34) | KAT2BDAPK3ROCK2CHEK2PIM1 | |
| SCHEMBL19286229 | 0.77 | KAT2B (0.37) | KAT2BIKZF2DAPK3ROCK2CHEK2 | |
| SCHEMBL19286269 | 0.75 | LMNA (0.35) | — | |
| SCHEMBL19286202 | 0.74 | CA12 (0.38) | — | |
| SCHEMBL17470133 | 0.71 | KAT2B (0.36) | KAT2BIKZF2 | |
| SCHEMBL19286303 | 0.68 | ACHE (0.33) | — | |
| SCHEMBL19286267 | 0.66 | ALDH1A1 (0.33) | — | |
| SCHEMBL19286232 | 0.66 | TRPA1 (0.33) | — | |
| SCHEMBL19286245 | 0.66 | TRPA1 (0.33) | — | |
| SCHEMBL19286316 | 0.63 | NR3C1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9744528-B2 | Metallorganocatalysis for asymmetric transformations | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-08-29 | — | — | US | disclosed |